돌발성 난청에서 스테로이드 투여 방법에 따른 치료 결과의 차이
The Comparison of Treatment Outcomes between IV and Oral Steroid in Sudden Sensorineural Hearing Loss ; Propensity Score Matching Analysis
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
The aims of the study was to compare the treatment outcomes associated with the steroid administration routes in unilateral sudden sensorineural hearing loss. Methods:From January 1998 to December 2014, three hundred and eighteen patients with unilateral sudden sensorineural hearing loss were assessed. Among them, 34 patients received the intravenous dexamethasone (16 mg/day)while the others 284 patients received 1mg/kg prednisolone daily with a subsequently tapered dose. We performed a propensity score matching analysis using previously known prognostic factors including initial hearing level, presence of vertigo and duration of onset of treatment to compare treatment outcome of IV and oral steroid. The hearing recovery between the IV steroid group and propensity score matched oral steroid group was assessed according to the AAO-HNS guideline and Siegel’s criteria. Results:In the comparison between oral and IV steroid group, mean age, the initial hearing level was significantly higher in the oral steroid group than in IV steroid group (p=0.002, p=0.003) After propensity score matching, initial hearing level, age, sex and other clinical parameters were not significantly different between IV steroid and matched oral steroid group. In the treatment outcome, the complete recovery rate in IV steroid and the oral steroid group were 64.7% and 47.1% respectively. Although the recovery rate of the IV steroid group was higher than that of the oral steroid group, statistical significance was not identified. Conclusions:The administration route of systemic steroid did not affect the clinical outcomes of idiopathic sudden sensorineural hearing loss.
Abstract
The aims of the study was to compare the treatment outcomes associated with the steroid administration routes in unilateral sudden sensorineural hearing loss. Methods:From January 1998 to December 2014, three hundred and eighteen patients with unilateral sudden sensorineural hearing loss were assessed. Among them, 34 patients received the intravenous dexamethasone (16 mg/day)while the others 284 patients received 1mg/kg prednisolone daily with a subsequently tapered dose. We performed a propensity score matching analysis using previously known prognostic factors including initial hearing level, presence of vertigo and duration of onset of treatment to compare treatment outcome of IV and oral steroid. The hearing recovery between the IV steroid group and propensity score matched oral steroid group was assessed according to the AAO-HNS guideline and Siegel’s criteria. Results:In the comparison between oral and IV steroid group, mean age, the initial hearing level was significantly higher in the oral steroid group than in IV steroid group (p=0.002, p=0.003) After propensity score matching, initial hearing level, age, sex and other clinical parameters were not significantly different between IV steroid and matched oral steroid group. In the treatment outcome, the complete recovery rate in IV steroid and the oral steroid group were 64.7% and 47.1% respectively. Although the recovery rate of the IV steroid group was higher than that of the oral steroid group, statistical significance was not identified. Conclusions:The administration route of systemic steroid did not affect the clinical outcomes of idiopathic sudden sensorineural hearing loss.
참고문헌 (22)
- Chau JK, "Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss", Laryngoscope, 120(5), pp.1011~1021 (2010)
- Stokroos R, "The etiology of idiopathic sudden sensorineural hearing loss. A review of the literature", Acta Oto-Rhino-Laryngologica Belgica, 50(1), pp.69~76 (1995)
- Chung JH, "Clinical significance of arterial stiffness in idiopathic sudden sensorineural hearing loss.", Laryngoscope, 126(8), pp.1918~1922 (2016)
- Egli Gallo D, "Effectiveness of systemic high-dose dexamethasone therapy for idiopathic sudden sensorineural hearing loss", Audiol Neurootol, 18(3), pp.161~170 (2013)
- Schreiber BE, "Sudden sensorineural hearing loss", Lancet, 375(9721), pp.1203~1211 (2010)
- Free RH, "Side effects of oral dexamethasone pulse therapy for idiopathic sudden sensorineural hearing loss", Otol Neurotol, 30(5), pp.691~ (2009)
- Meyer JS, "Is dexamethasone an effective alternative to oral prednisone in the treatment of pediatric asthma exacerbations?", Hosp Pediatr, 4(3), pp.172~180 (2014)
- Siegel L, "The treatment of idiopathic sudden sensorineural hearing loss", Otolaryngol clin North America, 8(2), pp.467~ (1975)
- Stachler RJ, "Clinical practice guideline sudden hearing loss", Otolaryngol Head Neck Surg, 146(3), pp.S1~S35 (2012)
- Chung JH, "Multivariate analysis of prognostic factors for idiopathic sudden sensorineural hearing loss in children", Laryngoscope, 125(9), pp.2209~2215 (2015)
- Byl FM, "Sudden hearing loss: eight years’ experience and suggested prognostic table", Laryngoscope, 94(5), pp.647~661 (1984)
- Gao Y, "Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss: a meta-analysis", Eur Arch Otorhinolaryngol, 273(11), pp.3699~3711 (2016)
- Rauch SD, "Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss:a randomized trial", Jama, 305(20), pp.2071~2079 (2011)
- 윤명하, "스테로이드의 사용지침", The Korean Journal of Pain, 17(2), pp.8~8 (2004), 대한통증학회
- Lester RS, "Corticosteroids", Clin Dermatol, 7(3), pp.80~97 (1989)
- Dixon JS, "Second-line agents in the treatment of rheumatic diseases", Ann Rheum Dis, 51(11), pp.1192~ (1992)
- Qureshi F, "Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma", J Pediatr, 139(1), pp.20~26 (2001)
- Parikh K, "Comparative effectiveness of dexamethasone versus prednisone in children hospitalized with asthma", J Pediatr, 167(3), pp.639~644 (2015)
- Ceviker Y, "Comparison of two systemic steroid regimens for the treatment of COPD exacerbations", Pulm Pharmacol Ther, 27(2), pp.179~183 (2014)
- Fitzgerald S., "High-dose oral steroids found to be as effective as IV steroids for MS relapses", Neurology Today, 14(13), pp.18~19 (2014)
- Kim JW, "Study of prognostic factor in sudden sensorineural hearing loss: a study of 78 cases", J Clin Otolaryngol, 15, pp.98~102 (2004)
- Yoon TH, "Histopathology of sudden hearing loss", Laryngoscope, 100(7), pp.707~715 (1990)
